Pediatric Medical Groups Oppose Age Restrictions On OTC Plan B
This article was originally published in The Tan Sheet
Current scientific data supports OTC availability for Barr's Plan B emergency contraceptive to adolescents under age 16, the American Academy of Pediatrics and Society for Adolescent Medicine maintain in a May 26 letter to FDA and Barr
You may also be interested in...
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill
Barr Labs will continue to work with FDA toward approval of emergency contraceptive Plan B (levonorgestrel .75 mg) for OTC use, the company said in a May 6 statement
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC